# The Efficacy of Surgical Treatment After Neoadjuvant Chemotherapy Plus Intraperitoneal Immunotherapy Versus Chemotherapy Alone for Patients With Positive Wash Cytology Gastric Cancer

> **NCT02976142** · PHASE2 · UNKNOWN · sponsor: **Moscow Clinical Scientific Center** · enrollment: 150 (estimated)

## Conditions studied

- Gastric Cancer, Metastatic

## Interventions

- **PROCEDURE:** neoadjuvant chemoimmunotherapy

## Key facts

- **NCT ID:** NCT02976142
- **Lead sponsor:** Moscow Clinical Scientific Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12
- **Primary completion:** 2018-11
- **Final completion:** 2020-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2016-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02976142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02976142, "The Efficacy of Surgical Treatment After Neoadjuvant Chemotherapy Plus Intraperitoneal Immunotherapy Versus Chemotherapy Alone for Patients With Positive Wash Cytology Gastric Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02976142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*